Access to anti-retroviral drugs, male in Sweden
Sweden: Access to anti-retroviral drugs, male was 95.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, male in Sweden, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Sweden is 95.0%, measured in 2022.
The figure is up 8.0% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Sweden peaked at 98.0% in 2018 and was at its lowest, 38.0%, in 2000.
Sweden ranks 4th of 141 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, male in Sweden, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 38.0% | — |
| 2001 | 39.0% | +2.6% |
| 2002 | 41.0% | +5.1% |
| 2003 | 49.0% | +19.5% |
| 2004 | 51.0% | +4.1% |
| 2005 | 53.0% | +3.9% |
| 2006 | 54.0% | +1.9% |
| 2007 | 62.0% | +14.8% |
| 2008 | 72.0% | +16.1% |
| 2009 | 78.0% | +8.3% |
| 2010 | 83.0% | +6.4% |
| 2011 | 85.0% | +2.4% |
| 2012 | 88.0% | +3.5% |
| 2013 | 92.0% | +4.5% |
| 2014 | 94.0% | +2.2% |
| 2015 | 95.0% | +1.1% |
| 2016 | 96.0% | +1.1% |
| 2017 | 97.0% | +1.0% |
| 2018 | 98.0% | +1.0% |
| 2019 | 97.0% | -1.0% |
| 2020 | 96.0% | -1.0% |
| 2021 | 95.0% | -1.0% |
| 2022 | 95.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 53.7% | 38.0% | 78.0% | 10 |
| 2010s | 92.5% | 83.0% | 98.0% | 10 |
| 2020s | 95.3% | 95.0% | 96.0% | 3 |
Countries ranked near Sweden
More gender data for Sweden
- Child population (UN estimates and projections) 1,663 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.5 % change on previous year (2030)
- Population 9,179 (2030)
- Working-age population (UN estimates and projections) 9,179 (2030)
- Population (UN estimates and projections), annual growth rate 0.6078 % change on previous year (2030)
- Age population, age 00, female, interpolated 47,810 (2025)
- Age population, age 00, male, interpolated 50,483 (2025)
- Age population, age 01, female, interpolated 48,381 (2025)
- Age population, age 01, male, interpolated 51,112 (2025)
- Age population, age 02, female, interpolated 50,315 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Sweden?
- Access to anti-retroviral drugs, male in Sweden was 95.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Sweden?
- The highest recorded value was 98.0% in 2018.
- What is the lowest access to anti-retroviral drugs, male recorded in Sweden?
- The lowest recorded value was 38.0% in 2000.
- How does Sweden rank for access to anti-retroviral drugs, male?
- Sweden ranks 4th out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, male rising or falling in Sweden?
- Over the last ten years it is up 8.0%. The long-run trend across the full record is rising.
- Where does this Sweden data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.